MeiraGTx Holdings plc Variable Lease, Cost
MeiraGTx Holdings plc (MGTX) reported Variable Lease, Cost of $317.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2026-08-13
- MeiraGTx Holdings plc variable lease, cost for the quarter ending 2026-06-30 was $317.00K, a 3.93% increase year-over-year.
- MeiraGTx Holdings plc variable lease, cost for the quarter ending 2026-03-31 was $313.00K, a 126.81% increase year-over-year.
- MeiraGTx Holdings plc variable lease, cost for the quarter ending 2025-12-31 was $326.00K, a 60.59% increase year-over-year.
- MeiraGTx Holdings plc variable lease, cost for the quarter ending 2025-09-30 was $304.00K, a 39.45% increase year-over-year.
- MeiraGTx Holdings plc variable lease, cost for fiscal 2025 was $1.22M, a 24.06% increase from fiscal 2024.
- MeiraGTx Holdings plc variable lease, cost for fiscal 2024 was $981.00K, a 12.72% decline from fiscal 2023.
- MeiraGTx Holdings plc variable lease, cost for fiscal 2023 was $1.12M, a 1.81% increase from fiscal 2022.
- MeiraGTx Holdings plc variable lease, cost for fiscal 2022 was $1.10M.
| Period end | Variable Lease, Cost 3 month | Variable Lease, Cost 6 month | Variable Lease, Cost 9 month | Variable Lease, Cost 12 month |
|---|---|---|---|---|
| 2026-06-30 | $317.00K 10-Q · filed 2026-08-13 | $630.00K 10-Q · filed 2026-08-13 | $956.00K derived: sum of 3 quarters · filed 2026-08-13 | $1.26M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $313.00K 10-Q · filed 2026-05-14 | $639.00K derived: sum of 2 quarters · filed 2026-05-14 | $943.00K derived: sum of 3 quarters · filed 2026-05-14 | $1.25M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $326.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $630.00K derived: sum of 2 quarters · filed 2026-03-30 | $935.00K derived: sum of 3 quarters · filed 2026-08-13 | $1.22M 10-K · filed 2026-03-30 |
| 2025-09-30 | $304.00K 10-Q · filed 2025-11-13 | $609.00K derived: sum of 2 quarters · filed 2026-08-13 | $891.00K 10-Q · filed 2025-11-13 | $950.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $305.00K 10-Q · filed 2026-08-13 | $588.00K 10-Q · filed 2026-08-13 | $646.00K derived: sum of 3 quarters · filed 2026-08-13 | $864.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $138.00K 10-Q · filed 2026-05-14 | $341.00K derived: sum of 2 quarters · filed 2026-05-14 | $559.00K derived: sum of 3 quarters · filed 2026-05-14 | $840.00K derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $203.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $421.00K derived: sum of 2 quarters · filed 2026-03-30 | $702.00K derived: sum of 3 quarters · filed 2026-03-30 | $981.00K 10-K · filed 2026-03-30 |
| 2024-09-30 | $218.00K 10-Q · filed 2025-11-13 | $499.00K derived: sum of 2 quarters · filed 2025-11-13 | $778.00K 10-Q · filed 2025-11-13 | $1.07M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $281.00K 10-Q · filed 2025-08-14 | $560.00K 10-Q · filed 2025-08-14 | $848.00K derived: sum of 3 quarters · filed 2025-08-14 | $1.12M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $281.00K 10-Q · filed 2025-05-13 | $567.00K derived: sum of 2 quarters · filed 2025-05-13 | $841.00K derived: sum of 3 quarters · filed 2025-05-13 | $1.12M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $286.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $560.00K derived: sum of 2 quarters · filed 2025-03-13 | $842.00K derived: sum of 3 quarters · filed 2025-03-13 | $1.12M 10-K · filed 2025-03-13 |
| 2023-09-30 | $274.00K 10-Q · filed 2024-11-13 | $556.00K derived: sum of 2 quarters · filed 2024-11-13 | $838.00K 10-Q · filed 2024-11-13 | $1.11M derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | $282.00K 10-Q · filed 2024-08-12 | $563.00K 10-Q · filed 2024-08-12 | $841.00K derived: sum of 3 quarters · filed 2024-08-12 | $1.10M derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | $281.00K 10-Q · filed 2024-05-09 | $559.00K derived: sum of 2 quarters · filed 2024-05-09 | $816.00K derived: sum of 3 quarters · filed 2024-05-09 | |
| 2022-12-31 | $278.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | $535.00K derived: sum of 2 quarters · filed 2024-03-15 | $1.10M 10-K · filed 2024-03-15 | |
| 2022-09-30 | $257.00K 10-Q · filed 2023-11-14 | $826.00K 10-Q · filed 2023-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Replimune Group, Inc. (REPL) | United States | $1.186B | -3.13 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |